1. Chang YS. Is it possible to predict and prevent adverse drug reactions? JPERM 2009;2:3–13.
2. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255–1259.
3. Kim MH, Jung HY, Sohn MK, et al. Clinical features of adverse drug reactions in a tertiary care hospital in Korea. Korean J Asthma Allergy Clin Immunol 2008;28:35–39.
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200–1205.
5. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med 2007;167:1752–1759.
6. Choi JH, Shin YS, Suh CH, Nahm DH, Park HS. The frequency of adverse drug reactions in a tertiary care hostpital in Korea. Korean J Med 2004;67:290–296.
7. Kim MG, Kang HR, Kim JH, et al. Analysis of adverse drug reactions collected by an electronic reporting system in a single hospital. Korean J Med 2009;77:601–609.
8. Park JW. Social burden of drug allergy and its prevention. Korean J Med 2014;87:647–651.
9. Roughead E, Pratt N, Peck R, Gilbert A. Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners. Pharmacoepidemiol Drug Saf 2007;16:797–803.
10. Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990;228:83–90.
11. Son MK, Lee YW, Jung HY, et al. Comparison of the Naranjo and WHO-Uppsala Monitoring Centre criteria for causality assessment of adverse drug reactions. Korean J Med 2008;74:181–187.
12. Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol 2001;2:349–351.
13. Rew SY, Koh YI, Shin HY, et al. Reporting and clinical features of adverse drug reactions from a single university hospital. Korean J Asthma Allergy Clin Immunol 2011;31:184–191.
14. Leone R, Sottosanti L, Luisa Iorio M, et al. Drug-related deaths: an analysis of the Italian spontaneous reporting database. Drug Saf 2008;31:703–713.
15. Wester K, Jönsson A, Spigset O, Hägg S. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden. Pharmacoepidemiol Drug Saf 2007;16:173–180.
16. Juntti-Patinen L, Neuvonen P. Drug-related deaths in a university central hospital. Eur J Clin Pharmacol 2002;58:479–482.
17. Vasić NR, Milenković BA, Pešut DP, Stević RS, Jovanović DM. Drug induced lung disease--amiodarone in focus. Med Pregl 2014;67:334–337.
18. Papiris SA, Triantafillidou C, Kolilekas L, Markoulaki D, Manali ED. Amiodarone: review of pulmonary effects and toxicity. Drug Saf 2010;33:539–558.
19. Tajiri J, Noguchi S. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid 2004;14:459–462.
20. Cooper DS. Antithyroid drugs. N Engl J Med 2005;352:905–917.
22. Hersch M, Raveh D, Izbicki G. Effect of intravenous propacetamol on blood pressure in febrile critically ill patients. Pharmacotherapy 2008;28:1205–1210.
23. Krajčová A, Matoušek V, Duška F. Mechanism of paracetamol-induced hypotension in critically ill patients: a prospective observational cross-over study. Aust Crit Care 2012;26:136–141.
24. Kim SH, Choi JH, Ahn Y, Park HS. A case of anaphylactic reaction to oral cefaclor. Korean J Med 2003;65(Suppl 3):S882–S884.
25. Byon JS, Lee YM, Kim YK, Kim KU, Uh S. A case of anaphylaxis after exposure to oral cefaclor. Korean J Asthma Allergy Clin Immunol 2008;28:231–233.
26. Nam YH, Kim JE, Hwang EK, et al. Clinical and immunologic evaluations of immediate hypersensitivity to cefaclor. Korean J Asthma Allergy Clin Immunol 2011;31:192–198.
27. Moon IJ, Park HJ, Kim SR, et al. Drug-induced anaphylaxis in a single Korean tertiary hospital. Korean J Med 2015;88:281–287.
28. Park KH, Pai J, Song DG, et al. Ranitidine-induced anaphylaxis: clinical features, cross-reactivity, and skin testing. Clin Exp Allergy 2016;46:631–639.
29. Capodanno D, Capranzano P, Giacchi G, Calvi V, Tamburino C. Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients. Int J Cardiol 2013;167:1237–1241.
30. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014;383:955–962.